![Jun Yoon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jun Yoon
Directeur Financier/CFO chez
STRUCTURE THERAPEUTICS INC.
Fortune : 35 M $ au 31/05/2026
Profil
Jun Yoon is currently Chief Operating Officer & Director at Shanghai ShouTi Biotechnology Co. Ltd. and Chief Financial Officer at Structure Therapeutics, Inc. Former positions include Senior Director-Licensing & Business Development at VIA Pharmaceuticals, Inc. from 2004 to 2010, Head-Business Development at Syrrx, Inc. from 2000 to 2002, and Vice President-Corporate Development at Cellerant Therapeutics, Inc. from 2010 to 2016.
Education includes an undergraduate degree from the University of California.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 2 683 830 ( 1,92% ) | 35 M $ | 31/05/2026 |
Postes actifs de Jun Yoon
| Sociétés | Poste | Début |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Directeur Financier/CFO | 01/05/2022 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Directeur des opérations | - |
Anciens postes connus de Jun Yoon
| Sociétés | Poste | Fin |
|---|---|---|
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Corporate Officer/Principal | 01/01/2016 |
| VIA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2010 |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Corporate Officer/Principal | 01/10/2002 |
Formation de Jun Yoon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Health Technology |
VIA Pharmaceuticals, Inc.
 VIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops compounds for the treatment of cardiovascular and metabolic disease | Health Technology |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
